US FDA puts Mersana Therapeutics's ovarian cancer study on hold

Mersana Therapeutics

15/06/2023 12:36

June 15 (Reuters) - Mersana Therapeutics Inc  MRSN.O 
said on Thursday that the U.S. Food and Drug Administration
(FDA) has issued a partial clinical hold on its ovarian cancer
drug study.

 (Reporting by Khushi Mandowara in Bengaluru; Editing by Savio
D'Souza)
 ((Khushi.Mandowara@thomsonreuters.com;))